RECIPHARM LABORATORIES, INC. 401(K) PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
RECIPHARM LABORATORIES, INC.
This 401(k) plan holds $15M in total assets and serves 232 participants as of 2023. It is sponsored by RECIPHARM LABORATORIES, INC. in North Carolina. The plan reported positive net income of $6M for the year.
What the Filing Says About RECIPHARM LABORATORIES, INC. 401(K) PLAN
RECIPHARM LABORATORIES, INC. 401(K) PLAN is a 401(k) retirement plan sponsored by RECIPHARM LABORATORIES, INC., headquartered in North Carolina. As of the 2023 Form 5500 filing, the plan reports $15M in total end-of-year assets and covers 232 participants across the Professional & Technical Services industry. The sponsor's EIN on file with the U.S. Department of Labor is 562041552, and the plan has been effective since 2002-01-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $9M at the beginning of 2023 to $15M at year-end — a gain of 72.0%. Net assets (after liabilities) closed the year at $15M, with reported net income of $6M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $9M |
| Total Assets (End of Year) | $15M |
| Net Assets (End of Year) | $15M |
| Net Income | $6M |
| Plan Type | 401(k) |
| Employer EIN | 562041552 |
| Plan Effective Date | 2002-01-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (RECIPHARM LABORATORIES, INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 38 | N/A |
| 2023 | 1 | 232 | $15M |
| 2024 | 1 | 216 | $18M |
Nearby 401(k) Plans in North Carolina
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- THE BANK OF AMERICA 401(K) PLAN $54.8B · 173,899
- HONEYWELL 401(K) PLAN $15.4B · 40,004
- DUKE ENERGY RETIREMENT SAVINGS PLAN $10.4B · 28,121
- TRUIST FINANCIAL CORPORATION 401(K) SAVINGS PLAN $10.1B · 55,480
- NUCOR CORPORATION PROFIT SHARING AND RETIREMENT SAVINGS PLAN $8.5B · 24,174
Related Data
Guides
Frequently Asked Questions
How much money is in the RECIPHARM LABORATORIES, INC. 401(K) PLAN? ▼
What type of plan is RECIPHARM LABORATORIES, INC. 401(K) PLAN? ▼
Who sponsors the RECIPHARM LABORATORIES, INC. 401(K) PLAN? ▼
How did RECIPHARM LABORATORIES, INC. 401(K) PLAN perform in 2023? ▼
Where can I find official filings for RECIPHARM LABORATORIES, INC. 401(K) PLAN? ▼
How does RECIPHARM LABORATORIES, INC. 401(K) PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 562041552.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.